Role of Ulinastatin, a trypsin inhibitor, in severe acute pancreatitis in critical care setting: A retrospective analysis
Open Access
- 1 June 2018
- journal article
- research article
- Published by Elsevier in Journal of Critical Care
- Vol. 45, 27-32
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Morphological changes of the pancreas in course of acute pancreatitis during treatment with UlinastatinPolish Journal of Surgery, 2013
- Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensusGut, 2012
- Incidence of individual organ dysfunction in fatal acute pancreatitis: analysis of 1024 death recordsHPB, 2009
- Inflammation, endothelium, and coagulation in sepsisJournal of Leukocyte Biology, 2007
- Acute Pancreatitis: Bench to the BedsideGastroenterology, 2007
- Selected biochemical parameters and ultrastructural picture of pancreas due to Ulinastatin treatment of experimental acute pancreatitisExperimental and Toxicologic Pathology, 2005
- Persistent organ failure during the first week as a marker of fatal outcome in acute pancreatitisGut, 2004
- Bikunin — not just a plasma proteinase inhibitorThe International Journal of Biochemistry & Cell Biology, 2000
- Human Urinary Trypsin Inhibitor, Urinastatin, Prevents Pancreatic Injuries Induced by Pancreaticobiliary Duct Obstruction With Cerulein Stimulation and Systemic Hypotension in the RatArchives of Surgery, 1993
- The Protective Effect of the Trypsin Inhibitor Urinastatin on Cerulein-Induced Acute Pancreatitis in RatsPancreas, 1988